Examination of the returned device confirms the reported event of trial breakage.The root cause is attributed to user technique and/or misuse as the initial report stated the trial was not fully seating prior to range of motion testing causing the reported breakage.(b)(4) was performed by commercialized product development on the attune femoral trial family and concluded there are no design improvements, protective measures or information for safety that would definitely reduce the risks associated with these complaints without potentially increasing/adding other risks.No further work required.Continue to monitor via (b)(4).Depuy considers the investigation closed at this time.Should the additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.
|